References
- Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health 2014;2:e106–16
- Bramley T, Peeples P, Walt JG, et al. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch Ophthalmol 2008;126:849–56
- Khandhadia S, Cherry J, Lotery AJ. Age-related macular degeneration. Adv Exp Med Biol 2012;724:15–36
- Humayun MS, Dorn JD, da Cruz L, et al. Interim results from the international trial of second sight's visual prosthesis. Ophthalmology 2012;119:779–88
- Bi A, Cui J, Ma YP, et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 2006;50:23–33
- Lamba DA, Gust J, Reh TA. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell 2009;4:73–9
- Banghart MR, Mourot A, Fortin DL, et al. Photochromic blockers of voltage-gated potassium channels. Angew Chem Int Ed (in English) 2009;48:9097–101
- Mourot A, Kienzler MA, Banghart MR, et al. Tuning photochromic ion channel blockers. ACS Chem Neurosci 2011;2:536–43
- Beharry AA, Woolley GA. Azobenzene photoswitches for biomolecules. Chem Soc Rev 2011;40:4422–37
- Sadovski O, Beharry AA, Zhang F, et al. Spectral tuning of azobenzene photoswitches for biological applications. Angew Chem Int Ed Engl 2009;48:1484–6
- Polosukhina A, Litt J, Tochitsky I, et al. Photochemical restoration of visual responses in blind mice. Neuron 2012;75:271–82
- Tochitsky I, Polosukhina A, Degtyar VE, et al. Restoring visual function to blind mice with a photoswitch that exploits electrophysiological remodeling of retinal ganglion cells. Neuron 2014;81:800–13
- Shive M, Anderson J. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28:5–24
- Bourges JL, Gautier SE, Delie F, et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci 2003;44:3562–9
- Kompella UB, Bandi N, Ayalasomayajula SP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci 2003;44:1192–201
- Sakai T, Kohno H, Ishihara T, et al. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Exp Eye Res 2006;82:657–63
- Zolnik BS, Burgess DJ. Evaluation of in vivo–in vitro release of dexamethasone from PLGA microspheres. J Control Release 2008;127:137–45
- Hamishehkar H, Emami J, Najafabadi AR, et al. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloids Surf B Biointerfaces 2009;74:340–9
- Vay K, Friess W, Scheler S. A detailed view of microparticle formation by in-process monitoring of the glass transition temperature. Eur J Pharm Biopharm 2012;81:399–408
- Frick KD, Walt JG, Chiang TH, et al. Direct costs of blindness experienced by patients enrolled in managed care. Ophthalmology 2008;115:11–17